Chia Tai Tianqing Pharmaceutical describes new HPK1 inhibitors for cancer
Sep. 22, 2023
Chia Tai Tianqing Pharmaceutical Group Co. Ltd. has identified mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1; HPK1; MEKKK1) inhibitors reported to be useful for the treatment of cancer.